CASI Pharmaceuticals Inc/ KYG1933S1012 /
| 2024-04-23 10:00:00 PM | Chg. +0.0800 | Volume | Bid1:56:08 AM | Ask1:56:08 AM | High | Low |
|---|---|---|---|---|---|---|
| 2.5100USD | +3.29% | 13,047 Turnover: 24,495.8188 |
2.4200Bid Size: 1,000 | 2.5100Ask Size: 100 | 2.5100 | 2.3601 |
GlobeNewswire
2021-09-30
Hangzhou Chance Pharmaceuticals Appoints Guobao Zhao as Senior Vice President
GlobeNewswire
2021-08-18
Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
GlobeNewswire
2019-04-10
Research Report Identifies CASI Pharmaceuticals, WestRock, H. B. Fuller, Osisko Gold Royalties, Kopi...
GlobeNewswire
2019-02-20
Report: Developing Opportunities within Pure Storage, Flowers Foods, Cognex, CASI Pharmaceuticals, E...
GlobeNewswire
2018-08-27
Factors of Influence in 2018, Key Indicators and Opportunity within Steelcase, SecureWorks, Clevelan...
GlobeNewswire
2018-06-25
Report: Exploring Fundamental Drivers Behind Cabot Oil & Gas, Chesapeake Lodging Trust, CASI Pharmac...
